Financhill
Sell
47

PNTG Quote, Financials, Valuation and Earnings

Last price:
$27.37
Seasonality move :
-11.09%
Day range:
$26.82 - $27.51
52-week range:
$13.77 - $37.13
Dividend yield:
0%
P/E ratio:
40.26x
P/S ratio:
1.29x
P/B ratio:
5.55x
Volume:
1.1M
Avg. volume:
247.2K
1-year change:
100.73%
Market cap:
$940.5M
Revenue:
$544.9M
EPS (TTM):
$0.68
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $338.5M $391M $439.7M $473.2M $544.9M
Revenue Growth (YoY) 18.34% 15.49% 12.47% 7.63% 15.14%
 
Cost of Revenues $293.9M $336.1M $391.1M $414.7M $477.9M
Gross Profit $44.6M $54.9M $48.6M $58.6M $67M
Gross Profit Margin 13.18% 14.04% 11.05% 12.38% 12.3%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $35.1M $31.3M $36.3M $34M $36.7M
Other Inc / (Exp) -- $225K -$2.9M -$7M $269K
Operating Expenses $38.9M $36M $41M $38.9M $41.8M
Operating Income $5.7M $18.9M $7.6M $19.7M $25.2M
 
Net Interest Expenses $410K $1.2M $1.9M $3.8M $5.9M
EBT. Incl. Unusual Items $5.3M $17.9M $2.7M $8.9M $19.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.1M $2.4M $582K $1.6M $5.7M
Net Income to Company $3.2M $15.6M $2.1M $7.2M $13.9M
 
Minority Interest in Earnings -$629K $191K $548K -$600K -$531K
Net Income to Common Excl Extra Items $2.5M $15.7M $2.7M $6.6M $13.4M
 
Basic EPS (Cont. Ops) $0.11 $0.56 $0.09 $0.23 $0.45
Diluted EPS (Cont. Ops) $0.11 $0.52 $0.09 $0.22 $0.44
Weighted Average Basic Share $27.8M $28M $28.4M $29.1M $29.9M
Weighted Average Diluted Share $29.6M $30.2M $30.6M $30.2M $30.2M
 
EBITDA $9.5M $23.8M $9.5M $17.6M $30.6M
EBIT $5.7M $19.1M $4.7M $12.7M $25.5M
 
Revenue (Reported) $338.5M $391M $439.7M $473.2M $544.9M
Operating Income (Reported) $5.7M $18.9M $7.6M $19.7M $25.2M
Operating Income (Adjusted) $5.7M $19.1M $4.7M $12.7M $25.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $98.4M $111.9M $118.4M $140.2M $180.7M
Revenue Growth (YoY) 11.31% 13.74% 5.74% 18.46% 28.89%
 
Cost of Revenues $85.2M $100M $104.1M $122.4M $155.4M
Gross Profit $13.2M $12M $14.3M $17.8M $25.3M
Gross Profit Margin 13.41% 10.69% 12.07% 12.7% 14.01%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.5M $9.1M $5.9M $9.4M $13M
Other Inc / (Exp) $225K -- -$23K -$38K $105K
Operating Expenses $8.7M $10.3M $7.1M $10.7M $14.5M
Operating Income $4.5M $1.7M $7.1M $7.1M $10.8M
 
Net Interest Expenses $192K $512K $1.1M $1.5M $2.9M
EBT. Incl. Unusual Items $4.5M $1.2M $6.1M $5.5M $8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $104K $69K $1.1M $1.1M $1.4M
Net Income to Company $4.4M $1.1M $5M $4.5M $6.7M
 
Minority Interest in Earnings -- $124K -$163K -$79K -$452K
Net Income to Common Excl Extra Items $4.4M $1.2M $4.8M $4.4M $6.2M
 
Basic EPS (Cont. Ops) $0.16 $0.04 $0.16 $0.15 $0.20
Diluted EPS (Cont. Ops) $0.15 $0.04 $0.16 $0.15 $0.20
Weighted Average Basic Share $28.1M $28.4M $29.3M $29.9M $30.3M
Weighted Average Diluted Share $30.2M $30.6M $30.2M $30.2M $31.4M
 
EBITDA $5.9M $2.9M $8.4M $8.3M $12.4M
EBIT $4.7M $1.7M $7.1M $7M $10.9M
 
Revenue (Reported) $98.4M $111.9M $118.4M $140.2M $180.7M
Operating Income (Reported) $4.5M $1.7M $7.1M $7.1M $10.8M
Operating Income (Adjusted) $4.7M $1.7M $7.1M $7M $10.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $372.5M $435.9M $460.3M $523.6M $652.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $321.5M $383.4M $406.9M $459.1M $564.8M
Gross Profit $51M $52.5M $53.4M $64.5M $87.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $33.1M $36.7M $34.8M $35.2M $46.1M
Other Inc / (Exp) $225K -$24K -$9.6M -$209K $1.2M
Operating Expenses $37.5M $41.5M $39.7M $40.3M $51.7M
Operating Income $13.4M $11M $13.7M $24.2M $35.8M
 
Net Interest Expenses $1.3M $1.7M $3.1M $5.7M $7.9M
EBT. Incl. Unusual Items $12.3M $9.3M $1M $18.4M $29.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.4M $933K -$190K $5.3M $6.7M
Net Income to Company $7.9M $8.3M $1.2M $13.1M $22.3M
 
Minority Interest in Earnings -- $533K -$181K -$564K -$1.2M
Net Income to Common Excl Extra Items $7.9M $8.9M $1M $12.5M $21.2M
 
Basic EPS (Cont. Ops) $0.29 $0.30 $0.03 $0.42 $0.70
Diluted EPS (Cont. Ops) $0.26 $0.29 $0.02 $0.42 $0.68
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $18.1M $15.7M $9M $29.1M $42.6M
EBIT $13.7M $11M $4.1M $24M $37M
 
Revenue (Reported) $372.5M $435.9M $460.3M $523.6M $652.3M
Operating Income (Reported) $13.4M $11M $13.7M $24.2M $35.8M
Operating Income (Adjusted) $13.7M $11M $4.1M $24M $37M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $283M $327.9M $348.6M $398.9M $506.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $243M $290.4M $306.2M $350.6M $437.6M
Gross Profit $40M $37.6M $42.4M $48.3M $68.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $21.7M $27.1M $25.7M $26.9M $36.3M
Other Inc / (Exp) $225K -$24K -$6.8M $24K $943K
Operating Expenses $25.1M $30.7M $29.3M $30.7M $40.6M
Operating Income $14.8M $6.9M $13.1M $17.6M $28.1M
 
Net Interest Expenses $896K $1.3M $2.5M $4.4M $6.3M
EBT. Incl. Unusual Items $14.2M $5.5M $3.8M $13.3M $22.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.4M $1M $241K $3.9M $5M
Net Income to Company $11.7M $4.5M $3.6M $9.4M $17.8M
 
Minority Interest in Earnings -- $342K -$387K -$351K -$1M
Net Income to Common Excl Extra Items $11.7M $4.8M $3.2M $9M $16.8M
 
Basic EPS (Cont. Ops) $0.43 $0.16 $0.11 $0.30 $0.55
Diluted EPS (Cont. Ops) $0.40 $0.16 $0.10 $0.30 $0.54
Weighted Average Basic Share $83.9M $85.1M $86.5M $89.5M $90.5M
Weighted Average Diluted Share $89.8M $92.1M $88.9M $90.5M $92.5M
 
EBITDA $18.5M $10.4M $10M $21.4M $33.4M
EBIT $15.1M $6.9M $6.3M $17.6M $29.1M
 
Revenue (Reported) $283M $327.9M $348.6M $398.9M $506.3M
Operating Income (Reported) $14.8M $6.9M $13.1M $17.6M $28.1M
Operating Income (Adjusted) $15.1M $6.9M $6.3M $17.6M $29.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $402K $43K $5.2M $2.1M $6.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $32.2M $47.2M $53.9M $53.4M $61.1M
Inventory -- -- -- -- --
Prepaid Expenses $6.1M $12.3M -- -- --
Other Current Assets -- -- $16.7M $18.3M $12.9M
Total Current Assets $38.7M $59.6M $75.8M $73.8M $80.1M
 
Property Plant And Equipment $331M $326.5M $317.8M $287.5M $291.5M
Long-Term Investments -- -- -- -- --
Goodwill $41.2M $66.4M $74.3M $79.5M $91M
Other Intangibles $33.5M $47.5M $53.7M $58.6M $67.7M
Other Long-Term Assets $3.4M $4.8M $4.8M $10.5M $9.3M
Total Assets $447.8M $507M $530.3M $512.1M $539.7M
 
Accounts Payable $8.7M $9.8M $10.6M $13.6M $10.8M
Accrued Expenses $25M $37.5M $33.1M $33.6M $38.3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $12.3M $14.1M $16.1M $16.6M $17.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $51.2M $89M $71.6M $70.2M $71.5M
 
Long-Term Debt $18.5M $8.3M $51.4M $62.9M $63.9M
Capital Leases -- -- -- -- --
Total Liabilities $376.6M $405.8M $416.1M $386.5M $394.2M
 
Common Stock $28K $28K $28K $29K $29K
Other Common Equity Adj -- -- -- -- --
Common Equity $71.1M $96.6M $110.2M $121M $140.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $4.6M $4M $4.6M $5.2M
Total Equity $71.1M $101.2M $114.2M $125.7M $145.5M
 
Total Liabilities and Equity $447.8M $507M $530.3M $512.1M $539.7M
Cash and Short Terms $402K $43K $5.2M $2.1M $6.1M
Total Debt $18.5M $8.3M $51.4M $62.9M $63.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $8.3M $3.7M $3M $3.4M $4.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $35.9M $53.4M $51.6M $59.4M $84M
Inventory -- -- -- -- --
Prepaid Expenses $9.3M $17.9M $12.3M -- --
Other Current Assets -- -- -- $9.5M $13.3M
Total Current Assets $53.5M $75M $66.9M $72.2M $101.8M
 
Property Plant And Equipment $328.7M $318.2M $286.6M $291M $307.3M
Long-Term Investments -- -- -- -- --
Goodwill $49.1M $73.8M $79.2M $86.1M $129.3M
Other Intangibles $40.1M $54.2M $58.5M $62.9M $95.9M
Other Long-Term Assets $8.8M $6M $10.7M $8M $12.2M
Total Assets $480.1M $529.2M $504.9M $520.3M $646.8M
 
Accounts Payable $7.8M $9.8M $12.8M $12.2M $15.9M
Accrued Expenses $28.7M $32.7M $38.5M $34.6M $49.9M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $13.9M $15.4M $15.9M $16.3M $19.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $83.3M $76.5M $72.8M $68.8M $90.6M
 
Long-Term Debt $696K $42.7M $55.8M $53.8M $108.9M
Capital Leases -- -- -- -- --
Total Liabilities $390.8M $415.4M $384M $380.8M $459.5M
 
Common Stock $28K $28K $29K $29K $31K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $4.3M $4.4M $5M $17.9M
Total Equity $89.3M $113.8M $120.8M $139.5M $187.3M
 
Total Liabilities and Equity $480.1M $529.2M $504.9M $520.3M $646.8M
Cash and Short Terms $8.3M $3.7M $3M $3.4M $4.5M
Total Debt $696K $42.7M $55.8M $53.8M $108.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.2M $15.6M $2.1M $7.2M $13.9M
Depreciation & Amoritzation $3.8M $4.7M $4.8M $4.9M $5.1M
Stock-Based Compensation $3.4M $8.3M $10M $3.1M $5.4M
Change in Accounts Receivable -$8.6M -$15.7M -$7.3M -$361K -$7.4M
Change in Inventories -- -- -- -- --
Cash From Operations $9.6M $50.2M -$18.2M $9M $33.1M
 
Capital Expenditures $6.7M $7.3M $6.3M $14.2M $8.1M
Cash Acquisitions -$18.8M -$33.2M -$13.6M -$10.1M -$21.4M
Cash From Investing -$26.5M -$41.6M -$20.1M -$24.2M -$30.2M
 
Dividends Paid (Ex Special Dividend) -$11.6M -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $42.5M $52.7M $125.5M $129.5M $182M
Long-Term Debt Repaid -$22.5M -$63.2M -$81.5M -$118.5M -$181.5M
Repurchase of Common Stock -$2.7M -$65K -- -- --
Other Financing Activities $9.2M $477K -$1.4M -- --
Cash From Financing $17.3M -$8.9M $43.5M $12.1M $1.1M
 
Beginning Cash (CF) $41K $402K $43K $5.2M $2.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $361K -$359K $5.1M -$3.1M $4M
Ending Cash (CF) $402K $43K $5.2M $2.1M $6.1M
 
Levered Free Cash Flow $2.8M $43M -$24.5M -$5.1M $25M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.4M $1.1M $5M $4.5M $6.7M
Depreciation & Amoritzation $1.2M $1.2M $1.3M $1.3M $1.5M
Stock-Based Compensation $2.1M $2.6M -$2.7M $1.3M $2.1M
Change in Accounts Receivable -$2.1M -$1.3M $1.3M -$2.9M -$8.1M
Change in Inventories -- -- -- -- --
Cash From Operations $9.7M -$1.3M $8.1M $12.4M $7.7M
 
Capital Expenditures $1.7M $1.7M $2.6M $1.8M $908K
Cash Acquisitions -$7.2M -$750K -$8.9M -$4.4M -$31.7M
Cash From Investing -$13.8M -$2.6M -$11.4M -$6.4M -$33M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2M $26.5M $41M $37.5M $175.5M
Long-Term Debt Repaid -$2M -$22M -$38.5M -$43M -$145.5M
Repurchase of Common Stock -$8K -- -- -- --
Other Financing Activities -$52K -- -- -- -$3.9M
Cash From Financing $277K $4.7M $3.1M -$5.5M $26.7M
 
Beginning Cash (CF) $12.1M $2.9M $3.2M $2.8M $3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.8M $828K -$245K $545K $1.4M
Ending Cash (CF) $8.3M $3.7M $3M $3.4M $4.5M
 
Levered Free Cash Flow $8M -$3M $5.5M $10.6M $6.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.9M $8.3M $1.2M $13.1M $22.3M
Depreciation & Amoritzation $4.4M $4.8M $4.9M $5M $5.6M
Stock-Based Compensation $8M $9.8M $4.6M $5M $6.8M
Change in Accounts Receivable -$6.4M -$18.2M $1.1M -$7.7M -$25.3M
Change in Inventories -- -- -- -- --
Cash From Operations $50.4M -$15.9M $7.8M $24M $23.9M
 
Capital Expenditures $9.8M $3.7M $12.6M $9.5M $8M
Cash Acquisitions -$14.1M -$32.7M -$9.7M -$12.1M -$58.1M
Cash From Investing -$31.5M -$32.1M -$22.2M -$21.6M -$78.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $71M $121.2M $110.5M $179M $360M
Long-Term Debt Repaid -$69M -$78.2M -$98M -$181.5M -$302M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.6M -$839K -- -- --
Cash From Financing -$10.6M $43.4M $13.7M -$1.9M $56.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $8.3M -$4.6M -$752K $428K $1.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $40.7M -$19.7M -$4.8M $14.5M $15.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $11.7M $4.5M $3.6M $9.4M $17.8M
Depreciation & Amoritzation $3.4M $3.5M $3.7M $3.8M $4.3M
Stock-Based Compensation $6M $7.5M $2.1M $4M $5.4M
Change in Accounts Receivable -$4.2M -$6.7M $1.7M -$5.6M -$23.5M
Change in Inventories -- -- -- -- --
Cash From Operations $53.1M -$13.1M $13M $27.9M $18.7M
 
Capital Expenditures $7.7M $4.1M $10.4M $5.7M $5.7M
Cash Acquisitions -$14.1M -$13.6M -$9.7M -$11.7M -$48.4M
Cash From Investing -$27.6M -$18.1M -$20.2M -$17.6M -$66.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $28.5M $97M $82M $131.5M $309.5M
Long-Term Debt Repaid -$46.5M -$61.5M -$78M -$141M -$261.5M
Repurchase of Common Stock -$65K -- -- -- --
Other Financing Activities -$78K -$1.4M -- -- -$3.9M
Cash From Financing -$17.6M $34.8M $5M -$9M $46M
 
Beginning Cash (CF) $17.4M $8.5M $12M $7.9M $11.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $7.9M $3.7M -$2.2M $1.3M -$1.6M
Ending Cash (CF) $25.3M $12.2M $9.8M $9.2M $10.2M
 
Levered Free Cash Flow $45.4M -$17.2M $2.5M $22.2M $13.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock